SCHEMBL9954185

SCHEMBL9954185

CCCCCCCCCCCCCCCC(CC)C(CCCCCC)(OC(C)=O)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.38
FFAR1 O14842 1/20 0.38
FDPS P14324 1/20 0.37
MAPT P10636 1/20 0.37
LCK P06239 1/20 0.37
PPARD Q03181 1/20 0.37
ZDHHC20 Q5W0Z9 1/20 0.37
ZDHHC2 Q9UIJ5 1/20 0.37
HSPD1 P10809 1/20 0.36
BLM P54132 1/20 0.36
HSPE1 P61604 1/20 0.36
MEN1 O00255 1/20 0.36
HPGD P15428 1/20 0.36
RECQL P46063 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.36
FFAR4 Q5NUL3 1/20 0.35
ACE2 Q9BYF1 1/20 0.35
ACACB O00763 1/20 0.35
ACACA Q13085 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8099515 0.77 FFAR4 (0.35) GPR84FFAR1PPARDMEN1KMT2A
SCHEMBL7769547 0.77 FFAR4 (0.35) GPR84FFAR1PPARDMEN1KMT2A
Phosphine SCHEMBL10793480 0.75 FDPS (0.41) GPR84FFAR1FDPSMAPTLCK
SCHEMBL6258917 0.75 GPR84 (0.39) GPR84FFAR1FDPSMAPTLCK
SCHEMBL4907990 0.74 GPR84 (0.44) GPR84FFAR1FDPSMAPTLCK
SCHEMBL27737540 0.74 GPR84 (0.44) GPR84FFAR1FDPSMAPTLCK
SCHEMBL9500540 0.74 GPR84 (0.44) GPR84FFAR1FDPSMAPTLCK
SCHEMBL4907986 0.74 GPR84 (0.44) GPR84FFAR1FDPSMAPTLCK
SCHEMBL21269171 0.73 GPR84 (0.43) GPR84FFAR1FDPSMAPTLCK
SCHEMBL21270004 0.73 GPR84 (0.43) GPR84FFAR1FDPSMAPTLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4355291-B1 COSMETIC PRODUCT CONSISTING OF PACKAGING AND A PREPARATION CONTAINING ETHYLHEXYL OXYSTEARATE ESTER BEIERSDORF AG (DE) 2025-05-21 EP disclosed
EP-2654665-A2 METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH (DE) 2013-10-30 EP disclosed
WO-2012083906-A2 METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY MIKA PHARMA GESELLSCHAFT FÜR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) 2012-06-28 WO disclosed